Whitepaper: Drug repurposing strategies to shorten timelines
This whitepaper explores drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.
List view / Grid view
This whitepaper explores drug repurposing, where known clinical candidates or commercially approved molecules are evaluated for new targets and indications.
This webinar considers the fundamental importance of water system control within pharma processing and the best control and monitoring practices.
This whitepaper explores vaccine development during a pandemic, a response to complex challenges that traditional manufacturing methods will not solve.
Telstar promotes innovative aseptic production solutions in a setting marked by the new GMP Annex 1.
Everything you need to have confidence and compliance in your nitrosamine impurity analysis.
The future of sustainable LAL testing has arrived with ACC’s PyroSmart NextGen recombinant LAL reagent technology for bacterial endotoxin testing (BET).
Discover how to improve your microbial identification process, reduce costs and protect your manufacturing process and brand reputation.
Welcome to European Pharmaceutical Review’s Guide to Outsourcing. In this edition, Gil Roth, President of the Pharma & Biopharma Outsourcing Association (PBOA) reflects on the fortunes and challenges of the CDMO sector, highlighting their invaluable place in today’s drug development strategies, and Associates of Cape Cod and Charles River showcase…
RoslinCT and Connect 2 Cleanrooms have worked in partnership to deliver a world-class cell and gene therapy facility.
How to replace manual handling of pharmaceutical powders and tablets with automation to pave the way for continuous manufacturing.
This webinar considers the problems bacterial and fungal spores present for contamination control and remediation and disinfection strategies.
This whitepaper outlines the important components of an environmental monitoring programme, providing practical advice and best practice guidance.
This worksheet can be edited to include specifications discovered during your evaluation of Alternative Rapid Microbiological Method Technologies.
The global cell and gene therapy manufacturing services market is expected to grow at a CAGR of 12.4 percent in the next five years.
New report suggests the cell line development services market will witness a 14.3 percent CAGR between 2021 and 2030.